‘Electronic Inhaler’ for Rapid Delivery of Morphine in Cancer Pain

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 12
Volume 6
Issue 12

HAYWARD, Calif-Aradigm Corporation is working with SmithKline Beecham to develop a self-administered pulmonary drug delivery system to provide rapid pain relief. The new product is being developed for the treatment of cancer-related pain, especially breakthrough pain, as well as postoperative pain.

HAYWARD, Calif—Aradigm Corporation is working with SmithKline Beecham to develop a self-administered pulmonary drug delivery system to provide rapid pain relief. The new product is being developed for the treatment of cancer-related pain, especially breakthrough pain, as well as postoperative pain.

The companies describe the hand-held device, called the AERx Pain Management System, as an “electronic inhaler.” Its design combines Aradigm’s proprietary pulmonary delivery technology with disposable liquid morphine packets.

To prevent the possibility of overdosing or misuse, the design will include technology to identify the patient, as well as automatic recording of all dosage events.

In a phase I trial in healthy volunteers, the speed and reproducibility of morphine delivery via the lung using the AERx technology was comparable to that of morphine delivered intravenously, the companies said. Pivotal clinical trials are expected to start next year.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.